A citation-based method for searching scientific literature

Tuyana Malankhanova, Lyubov Suldina, Elena Grigor'eva, Sergey Medvedev, Julia Minina, Ksenia Morozova, Elena Kiseleva, Suren Zakian, Anastasia Malakhova. J Pers Med 2020
Times Cited: 7







List of co-cited articles
103 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
71

Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
Xiaohong Xu, Yilin Tay, Bernice Sim, Su-In Yoon, Yihui Huang, Jolene Ooi, Kagistia Hana Utami, Amin Ziaei, Bryan Ng, Carola Radulescu,[...]. Stem Cell Reports 2017
124
71

Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
Mahru C An, Ningzhe Zhang, Gary Scott, Daniel Montoro, Tobias Wittkop, Sean Mooney, Simon Melov, Lisa M Ellerby. Cell Stem Cell 2012
249
57

Polyglutamine Disease Modeling: Epitope Based Screen for Homologous Recombination using CRISPR/Cas9 System.
Mahru C An, Robert N O'Brien, Ningzhe Zhang, Biranchi N Patra, Michael De La Cruz, Animesh Ray, Lisa M Ellerby. PLoS Curr 2014
51
57

CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo.
Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
161
42

CRISPR provides acquired resistance against viruses in prokaryotes.
Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau, Melissa Richards, Patrick Boyaval, Sylvain Moineau, Dennis A Romero, Philippe Horvath. Science 2007
42

Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts.
Kyle D Fink, Peter Deng, Josh Gutierrez, Joseph S Anderson, Audrey Torrest, Anvita Komarla, Stefanos Kalomoiris, Whitney Cary, Johnathon D Anderson, William Gruenloh,[...]. Cell Transplant 2016
29
42

CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.
Su Yang, Renbao Chang, Huiming Yang, Ting Zhao, Yan Hong, Ha Eun Kong, Xiaobo Sun, Zhaohui Qin, Peng Jin, Shihua Li,[...]. J Clin Invest 2017
175
42

Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
Jun Wan Shin, Kyung-Hee Kim, Michael J Chao, Ranjit S Atwal, Tammy Gillis, Marcy E MacDonald, James F Gusella, Jong-Min Lee. Hum Mol Genet 2016
139
42

Breaking the code of DNA binding specificity of TAL-type III effectors.
Jens Boch, Heidi Scholze, Sebastian Schornack, Angelika Landgraf, Simone Hahn, Sabine Kay, Thomas Lahaye, Anja Nickstadt, Ulla Bonas. Science 2009
42

Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.
Jolene Ooi, Sarah R Langley, Xiaohong Xu, Kagistia H Utami, Bernice Sim, Yihui Huang, Nathan P Harmston, Yi Lin Tay, Amin Ziaei, Ruizhu Zeng,[...]. Cell Rep 2019
35
42

STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease.
Vladimir A Vigont, Dmitriy A Grekhnev, Olga S Lebedeva, Konstantin O Gusev, Egor A Volovikov, Anton Yu Skopin, Alexandra N Bogomazova, Lilia D Shuvalova, Olga A Zubkova, Ekaterina A Khomyakova,[...]. Front Cell Dev Biol 2021
7
42

Chromosomal instability during neurogenesis in Huntington's disease.
Albert Ruzo, Gist F Croft, Jakob J Metzger, Szilvia Galgoczi, Lauren J Gerber, Cecilia Pellegrini, Hanbin Wang, Maria Fenner, Stephanie Tse, Adam Marks,[...]. Development 2018
26
42

Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
Magdalena Dabrowska, Agata Ciolak, Emilia Kozlowska, Agnieszka Fiszer, Marta Olejniczak. Int J Mol Sci 2020
10
42

Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.
Ningzhe Zhang, Mahru C An, Daniel Montoro, Lisa M Ellerby. PLoS Curr 2010
180
42

Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.
P Conforti, D Besusso, V D Bocchi, A Faedo, E Cesana, G Rossetti, V Ranzani, C N Svendsen, L M Thompson, M Toselli,[...]. Proc Natl Acad Sci U S A 2018
85
42

Disease-specific induced pluripotent stem cells.
In-Hyun Park, Natasha Arora, Hongguang Huo, Nimet Maherali, Tim Ahfeldt, Akiko Shimamura, M William Lensch, Chad Cowan, Konrad Hochedlinger, George Q Daley. Cell 2008
42

Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Kazutoshi Takahashi, Koji Tanabe, Mari Ohnuki, Megumi Narita, Tomoko Ichisaka, Kiichiro Tomoda, Shinya Yamanaka. Cell 2007
42

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.
Stefano Camnasio, Alessia Delli Carri, Angelo Lombardo, Iwona Grad, Caterina Mariotti, Alessia Castucci, Björn Rozell, Pietro Lo Riso, Valentina Castiglioni, Chiara Zuccato,[...]. Neurobiol Dis 2012
130
42

Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting.
Carla Lopes, Yang Tang, Sandra I Anjo, Bruno Manadas, Isabel Onofre, Luís P de Almeida, George Q Daley, Thorsten M Schlaeger, Ana Cristina Carvalho Rego. Front Cell Dev Biol 2020
12
42

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.
Thomas Gaj, Charles A Gersbach, Carlos F Barbas. Trends Biotechnol 2013
42

Treatment of a Mouse Model of ALS by In Vivo Base Editing.
Colin K W Lim, Michael Gapinske, Alexandra K Brooks, Wendy S Woods, Jackson E Powell, M Alejandra Zeballos C, Jackson Winter, Pablo Perez-Pinera, Thomas Gaj. Mol Ther 2020
70
28

The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.
Josiane E Garneau, Marie-Ève Dupuis, Manuela Villion, Dennis A Romero, Rodolphe Barrangou, Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Alfonso H Magadán, Sylvain Moineau. Nature 2010
28

Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's disease.
Bryan Zeitler, Steven Froelich, Kimberly Marlen, David A Shivak, Qi Yu, Davis Li, Jocelynn R Pearl, Jeffrey C Miller, Lei Zhang, David E Paschon,[...]. Nat Med 2019
71
28

Origins of Programmable Nucleases for Genome Engineering.
Srinivasan Chandrasegaran, Dana Carroll. J Mol Biol 2016
147
28

A simple cipher governs DNA recognition by TAL effectors.
Matthew J Moscou, Adam J Bogdanove. Science 2009
28

Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains.
J Smith, M Bibikova, F G Whitby, A R Reddy, S Chandrasegaran, D Carroll. Nucleic Acids Res 2000
278
28

Search-and-replace genome editing without double-strand breaks or donor DNA.
Andrew V Anzalone, Peyton B Randolph, Jessie R Davis, Alexander A Sousa, Luke W Koblan, Jonathan M Levy, Peter J Chen, Christopher Wilson, Gregory A Newby, Aditya Raguram,[...]. Nature 2019
28

A TALE nuclease architecture for efficient genome editing.
Jeffrey C Miller, Siyuan Tan, Guijuan Qiao, Kyle A Barlow, Jianbin Wang, Danny F Xia, Xiangdong Meng, David E Paschon, Elo Leung, Sarah J Hinkley,[...]. Nat Biotechnol 2011
28

In vivo genome editing rescues photoreceptor degeneration via a Cas9/RecA-mediated homology-directed repair pathway.
Yuan Cai, Tianlin Cheng, Yichuan Yao, Xiao Li, Yuqian Ma, Lingyun Li, Huan Zhao, Jin Bao, Mei Zhang, Zilong Qiu,[...]. Sci Adv 2019
37
28

CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model.
Freja K Ekman, David S Ojala, Maroof M Adil, Paola A Lopez, David V Schaffer, Thomas Gaj. Mol Ther Nucleic Acids 2019
46
28

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
Alexis C Komor, Yongjoo B Kim, Michael S Packer, John A Zuris, David R Liu. Nature 2016
28

Introducing an Expanded Trinucleotide Repeat Tract into the Human Genome for Huntington's Disease Modeling In Vitro.
Tuyana Malankhanova, Michael Sorokin, Sergey Medvedev, Suren Zakian, Anastasia Malakhova. Curr Protoc Hum Genet 2020
3
66


CRISPR/Cas, the immune system of bacteria and archaea.
Philippe Horvath, Rodolphe Barrangou. Science 2010
28

Introducing an expanded CAG tract into the huntingtin gene causes a wide spectrum of ultrastructural defects in cultured human cells.
Ksenia N Morozova, Lyubov A Suldina, Tuyana B Malankhanova, Elena V Grigor'eva, Suren M Zakian, Elena Kiseleva, Anastasia A Malakhova. PLoS One 2018
11
28

Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.
Wojciech J Szlachcic, Pawel M Switonski, Wlodzimierz J Krzyzosiak, Marek Figlerowicz, Maciej Figiel. Dis Model Mech 2015
34
28

Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
Rebecca Aron, Pasquale Pellegrini, Edward W Green, Daniel C Maddison, Kwadwo Opoku-Nsiah, Ana Osório Oliveira, Jinny S Wong, Aaron C Daub, Flaviano Giorgini, Paul Muchowski,[...]. Nat Commun 2018
31
28

Striatal neurons directly converted from Huntington's disease patient fibroblasts recapitulate age-associated disease phenotypes.
Matheus B Victor, Michelle Richner, Hannah E Olsen, Seong Won Lee, Alejandro M Monteys, Chunyu Ma, Christine J Huh, Bo Zhang, Beverly L Davidson, X William Yang,[...]. Nat Neurosci 2018
112
28


Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery.
Chiara Zuccato, Daniel Liber, Catarina Ramos, Alessia Tarditi, Dorotea Rigamonti, Marzia Tartari, Marta Valenza, Elena Cattaneo. Pharmacol Res 2005
143
28

The difficulty to model Huntington's disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells.
Kim Le Cann, Alec Foerster, Corinna Rösseler, Andelain Erickson, Petra Hautvast, Sebastian Giesselmann, Daniel Pensold, Ingo Kurth, Markus Rothermel, Virginia B Mattis,[...]. Sci Rep 2021
7
28


Mutant Huntingtin Disrupts the Nuclear Pore Complex.
Jonathan C Grima, J Gavin Daigle, Nicolas Arbez, Kathleen C Cunningham, Ke Zhang, Joseph Ochaba, Charlene Geater, Eva Morozko, Jennifer Stocksdale, Jenna C Glatzer,[...]. Neuron 2017
175
28

Role of brain-derived neurotrophic factor in Huntington's disease.
Chiara Zuccato, Elena Cattaneo. Prog Neurobiol 2007
393
28

Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells.
Kitai Kim, Rui Zhao, Akiko Doi, Kitwa Ng, Juli Unternaehrer, Patrick Cahan, Hongguang Huo, Yuin-Han Loh, Martin J Aryee, M William Lensch,[...]. Nat Biotechnol 2011
404
28

Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease.
Swati Naphade, Alexander Embusch, Kuruwitage Lakshika Madushani, Karen L Ring, Lisa M Ellerby. Front Neurosci 2018
16
28

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.
C A Gutekunst, S H Li, H Yi, J S Mulroy, S Kuemmerle, R Jones, D Rye, R J Ferrante, S M Hersch, X J Li. J Neurosci 1999
624
28


Patient-Specific iPSC-Based Models of Huntington's Disease as a Tool to Study Store-Operated Calcium Entry Drug Targeting.
Vladimir Vigont, Evgeny Nekrasov, Alexey Shalygin, Konstantin Gusev, Sergey Klushnikov, Sergey Illarioshkin, Maria Lagarkova, Sergey L Kiselev, Elena Kaznacheyeva. Front Pharmacol 2018
14
28


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.